SageMedic
Dr. Brian Leyland-Jones is a Chief Medical Officer and Scientific Advisory Board Member for the National Foundation for Cancer Research and Chief Scientific Officer of The Darwin Foundation. Dr. Leyland-Jones held leadership positions at Cornell, the Memorial Sloan Kettering Cancer Center, Emory University, and the NCI, and helped develop leading drugs for breast cancer (platinum drugs), and targeted therapies trastuzumab (Herceptin®) and bevacizumab (Avastin®).
This person is not in the org chart
This person is not in any teams
This person is not in any offices
SageMedic
SageMedic uses a patient’s live biopsy to create hundreds of 3D tumor replicates in the lab so that they can identify the most effective treatment within just one week.